AR and urinary bladder neoplasm: In our meta-analysis [25], AR expression in NMI bladder tumors was found to associate with better recurrence-free survival [hazard ratio (HR) = 0.593; 95% CI = 0.408–0.860; p = 0.006], but not with progression-free survival (p = 0.223).